March 29 (Reuters) - Cumberland Pharmaceuticals Inc
CPIX.O :
* CUMBERLAND PHARMACEUTICALS ANNOUNCES STRATEGIC REVIEW
* CUMBERLAND PHARMACEUTICALS - IN ADDITION TO PRODUCT
REVIEW, WILL
ALSO EVALUATE APPROPRIATE LEVEL OF SALES AND MEDICAL SUPPORT FOR
ITS LINE OF PRODUCTS
* CUMBERLAND PHARMACEUTICALS - STRATEGIC REVIEW WILL SEEK TO
ENSURE NATIONAL COVERAGE OF MAJORITY OF EACH BRAND'S CURRENT
BUSINESS, & ITS POTENTIAL
* CUMBERLAND PHARMACEUTICALS - BOTH EXPANSION OF INTERNAL
SALES
ORGANIZATION & AUGMENTED SUPPORT FROM CO-PROMOTION PARTNERS TO
BE CONSIDERED DURING REVIEW
* CUMBERLAND PHARMACEUTICALS INC - COMMENCED STRATEGIC
REVIEW OF
BRANDED PRODUCT PORTFOLIO, & ROSTER OF INTERNATIONAL PARTNERS
* CUMBERLAND PHARMACEUTICALS - EXPECTS TO COMMUNICATE
RESULTS FROM
REVIEW DURING UPCOMING REPORT ON Q1 OF 2019
Source text for Eikon: urn:newsml:reuters.com:*:nPn8wdBRTa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))